International Myeloma Foundation
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest global organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
Your support helps us provide a wide range of programs and services to the myeloma community in the areas of Research, Education, Support, and Advocacy.
The International Myeloma Foundation is a 501(c)(3) organization.
Learn more at https://www.myeloma.org
Will Myeloma Ever Be Curable? Answering Real Multiple Myeloma Patient Questions
You’re Not Alone: Join a Myeloma Support Group Today
What’s the ‘Right’ Answer? – Controversies in Myeloma
Multiple Myeloma Documentary 2024: Iceland Cycling Expedition for Research & Hope
Your Myeloma Questions Answered: PET Scans, Side Effects, and New Treatment Options
The International Myeloma Foundation | 35 Years
25 лет с множественной миеломой: путь надежды и стойкости Майкла и Робин Туохи
Тлеющая миелома высокого риска и новые методы лечения на передовой: что нужно знать пациентам | I...
Обзор IMS: победы на передовой, анализ высокого риска и перспективы развития миеломы | Часть 1 из 2
Kathy’s Myeloma Journey | Stem Cell Transplants, Relapse, and Clinical Trials
Крути педали. Меняй жизни. Исландская велоэкспедиция 2026 года по борьбе с множественной миеломой
Alma’s Myeloma Journey | Clinical Trials, Advocacy, and Thriving After Diagnosis
Living Well with Myeloma: Infection Prevention and Management
Terrence & Toni’s Myeloma Journey | Love, Advocacy and 10 Years of Hope
Replay the Facebook Live from 9/30 | Beth Faiman Discusses Frontline CAR T, Cevostamab, Trispecifics
Replay the Facebook Live from 9/8 | Dr. Joseph Mikhael Answers CAR T, MRD Negativity & Myeloma
Joan’s Myeloma Journey | Clinical Trials, Family Support, and Living with Myeloma
Diagnosed with Myeloma at 34: Thomas Shares His Stem Cell Transplant & Clinical Trial Experience
Is CAR T-Cell Therapy the Closest Thing to a Myeloma Cure? | CAR T-Cell Therapy Explained
CAR T-cell Therapy & MRD Negativity in Myeloma: What Patients Need to Know
Blood Cells and Multiple Myeloma: What You Need to Know | Understanding Anemia & Other Effects
Will We Ever Screen for Multiple Myeloma? | Early Detection of Myeloma
Bispecific Antibodies Explained: How Bispecific Antibodies Use the Immune System
Types of Multiple Myeloma & Why They Matter for Patients | #KnowMyeloma
Who’s Most Likely to Get Multiple Myeloma? | Risk by Age, Gender & Race Explained
How Common Is Multiple Myeloma? The Truth About This Lesser Known Blood Cancer
Controversies in Myeloma: Smoldering, Transplant vs CAR T, Dex, Maintenance & Bispecific Sequencing
Closing the Gap in Myeloma: Health Disparities, Delayed Diagnosis & the IMF M-Power Program
Managing Myeloma Symptoms: Infection Prevention, Bone Health, Kidney Care & Side Effect Management
U.S. Policy Updates 2025: Medicare Cap, Drug Parity, Telehealth, and How Patients Can Get Involved